Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 69.53%
August 31, 2026 69.53%
July 31, 2026 69.53%
June 30, 2026 69.53%
May 31, 2026 69.53%
April 30, 2026 69.53%
March 31, 2026 69.53%
February 28, 2026 69.53%
January 31, 2026 69.53%
December 31, 2025 69.53%
November 30, 2025 69.53%
October 31, 2025 69.53%
September 30, 2025 69.53%
August 31, 2025 69.53%
July 31, 2025 69.53%
June 30, 2025 69.53%
May 31, 2025 69.53%
April 30, 2025 69.53%
March 31, 2025 66.57%
February 28, 2025 66.57%
January 31, 2025 66.57%
December 31, 2024 66.57%
November 30, 2024 66.57%
October 31, 2024 65.00%
September 30, 2024 65.00%
Date Value
August 31, 2024 65.00%
July 31, 2024 65.00%
June 30, 2024 63.71%
May 31, 2024 63.71%
April 30, 2024 63.71%
March 31, 2024 63.71%
February 29, 2024 63.71%
January 31, 2024 63.71%
December 31, 2023 63.71%
November 30, 2023 63.71%
October 31, 2023 63.71%
September 30, 2023 52.08%
August 31, 2023 52.08%
July 31, 2023 52.08%
June 30, 2023 52.08%
May 31, 2023 52.08%
April 30, 2023 52.08%
March 31, 2023 52.08%
February 28, 2023 52.08%
January 31, 2023 52.08%
December 31, 2022 52.08%
November 30, 2022 52.08%
October 31, 2022 52.08%
September 30, 2022 46.93%
August 31, 2022 34.67%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Evotec SE 94.17%
Gerresheimer AG 85.05%
Lifecore Biomedical, Inc. 89.19%
Mesa Laboratories, Inc. 82.43%
Repligen Corp. 68.27%